1-6 of 6
Lars H. Jensen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SAR analysis of substituted purines as topoisomerase II inhibitors identifies ATPase inhibitors with nanomolar activity.

Lars H. Jensen, Peter B. Jensen, Robert H. Shoemaker, Maxwell Sehested
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1301.
Published: 15 April 2006
View articletitled, SAR analysis of substituted purines as topoisomerase II inhibitors identifies ATPase inhibitors with nanomolar activity.
Journal Articles

A transgenic mouse model for analyzing the role of topoisomerase II in mediating the pharmacological effects of dexrazoxane.

Morten Grauslund, Annemette V. Thougaard, Annette Füchtbauer, Kenneth F. Hofland, Peter Hjorth, Seppo Langer, Peter B. Jensen, Lars H. Jensen, Ernst-Martin Füchtbauer, Maxwell Sehested
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1298.
Published: 15 April 2006
View articletitled, A transgenic mouse model for analyzing the role of topoisomerase II in mediating the pharmacological effects of dexrazoxane.
Journal Articles

Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors

Lars H. Jensen, Annemette V. Thougaard, Morten Grauslund, Birgitte Søkilde, Elisabeth V. Carstensen, Henrik K. Dvinge, Dominic A. Scudiero, Peter B. Jensen, Robert H. Shoemaker, Maxwell Sehested
Journal: Cancer Research
Cancer Res (2005) 65 (16): 7470–7477.
https://doi.org/10.1158/0008-5472.CAN-05-0707
Published: 15 August 2005
View articletitled, Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors
Open the PDF for Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors in another window
Journal Articles

A C6-substituted guanine analog defines a novel class of ATP catalytic topoisomerase II inhibitors

Lars H. Jensen, Annemette Tuogaard, Birgitte Sokilde, Henrik K. Dvinge, Morten Grauslund, Elisabeth V. Carstensen, Eric Santoni-Rugiu, Dominic A. Scudiero, Robert H. Shoemaker, Peter B. Jensen, Maxwell Sehested
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 933–934.
Published: 01 May 2005
View articletitled, A C6-substituted guanine analog defines a novel class of ATP catalytic topoisomerase II inhibitors
Journal Articles

Human Small Cell Lung Cancer NYH Cells Selected for Resistance to the Bisdioxopiperazine Topoisomerase II Catalytic Inhibitor ICRF-187 Demonstrate a Functional R162Q Mutation in the Walker A Consensus ATP Binding Domain of the α Isoform

Irene Wessel, Lars H. Jensen, Peter B. Jensen, Jacob Falck, Angela Rose, Mikael Roerth, John L. Nitiss, Maxwell Sehested
Journal: Cancer Research
Cancer Res (1999) 59 (14): 3442–3450.
Published: 15 July 1999
View articletitled, Human Small Cell Lung Cancer NYH Cells Selected for Resistance to the Bisdioxopiperazine Topoisomerase II Catalytic Inhibitor ICRF-187 Demonstrate a Functional R162Q Mutation in the Walker A Consensus ATP Binding Domain of the α Isoform
Open the PDF for Human Small Cell Lung Cancer NYH Cells Selected for Resistance to the Bisdioxopiperazine Topoisomerase II Catalytic Inhibitor ICRF-187 Demonstrate a Functional R162Q Mutation in the Walker A Consensus ATP Binding Domain of the α Isoform in another window
Journal Articles

Chinese Hamster Ovary Cells Resistant to the Topoisomerase II Catalytic Inhibitor ICRF-159: A Tyr49Phe Mutation Confers High-Level Resistance to Bisdioxopiperazines

Maxwell Sehested, Irene Wessel, Lars H. Jensen, Bente Holm, Roberto S. Oliveri, Sue Kenwrick, Andrew M. Creighton, John L. Nitiss, Peter B. Jensen
Journal: Cancer Research
Cancer Res (1998) 58 (7): 1460–1468.
Published: 01 April 1998
View articletitled, Chinese Hamster Ovary Cells Resistant to the Topoisomerase II Catalytic Inhibitor ICRF-159: A Tyr49Phe Mutation Confers High-Level Resistance to Bisdioxopiperazines
Open the PDF for Chinese Hamster Ovary Cells Resistant to the Topoisomerase II Catalytic Inhibitor ICRF-159: A Tyr49Phe Mutation Confers High-Level Resistance to Bisdioxopiperazines in another window